Q1 FY27 Results: Revenue down, PAT up modestly

Revenue declinedResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-7.5%Reaction day

₹187.00

prior close

₹172.95

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-7.7% vs market

Pharmaceuticals peers, median of 167sector-0.3%-7.2% vs sector

On the reaction day the stock moved 7.7 pts less than Nifty Microcap 250 and 7.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.0

15m

-0.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-7.5+0.1-7.7-0.3-7.2

Next day

-12.1+0.5-12.6-0.0-12.1

-15.5-0.1-15.4-0.7-14.8

-15.1+0.4-15.5-0.4-14.7

-17.6+0.7-18.3-0.7-17.0

-18.2+0.9-19.1-0.5-17.6

-19.7+1.1-20.8-0.7-19.0

15d

-18.2+1.6-19.8+1.4-19.6

-15.6-0.7-14.8+0.6-16.2

-27.8-3.2-24.6-4.1-23.7

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vasundhara Rasayans reported Q1 FY27 results. Net sales fell to Rs 693.23 lakhs from Rs 756.15 lakhs YoY, an 8.3 percent decline. Total income dropped to Rs 730.10 from Rs 824.50 lakhs. However, PAT rose 13 percent to Rs 64.80 lakhs from Rs 57.28 lakhs, with EPS at Rs 2.04 versus Rs 1.80. Statutory auditors gave an unmodified review opinion. The company operates in the agri products segment.

Likely market impact

Mixed quarter: revenue decline of about 8 percent but PAT grew 13 percent. Modest positive for shareholders given earnings improvement.